Feed KLRS
KL
Kalaris Therapeutics Inc
KLRS · NASDAQ
$4.08 +1.49% (+$0.06)
1M -11.50%
Market Cap $84.7M
P/E Ratio -
Div. Yield -
ROE 72.78%
Bulios Fair Price
$2.69
34.1% downside
Preț actual
$4.08
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile KLRS sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/B 1.24x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 46.68%
ROE 72.78%
ROA 40.16%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 12.14x
Int. coverage N/A
Stability
28 /100
Unstable Beta 0.19x
EPS volatility 32.99%
Profitable years 0
Întreabă StockBot despre KLRS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew Oxtoby
Employees
20
Headquarters
Berkeley Heights
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report